Home524816 • BOM
add
Natco Pharma Ltd
Nakaraang pagsara
₹924.15
Sakop ng araw
₹889.45 - ₹923.05
Sakop ng taon
₹660.05 - ₹1,638.35
Market cap
164.00B INR
Average na Volume
68.12K
P/E ratio
8.71
Dividend yield
0.65%
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 12.21B | 13.95% |
Gastos sa pagpapatakbo | 5.22B | 16.26% |
Net na kita | 4.07B | 5.25% |
Net profit margin | 33.30 | -7.63% |
Kita sa bawat share | 22.70 | 5.29% |
EBITDA | 5.09B | 3.21% |
Aktuwal na % ng binabayarang buwis | 19.75% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 29.17B | 109.70% |
Kabuuang asset | 86.31B | 24.97% |
Kabuuang sagutin | 10.18B | -3.29% |
Kabuuang equity | 76.12B | — |
Natitirang share | 179.12M | — |
Presyo para makapag-book | 2.18 | — |
Return on assets | — | — |
Return on capital | 14.74% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 4.07B | 5.25% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Itinatag
1981
Headquarters
Website
Mga Empleyado
4,016
